These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 5516107)

  • 1. [Clinical experience with a new hypotensive drug: 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST-155)].
    Langer-Costanzi M
    Clin Ter; 1970 Dec; 55(5):419-31. PubMed ID: 5516107
    [No Abstract]   [Full Text] [Related]  

  • 2. Blind trial with 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155) in essential hypertension. Effects on arterial blood pressures at rest and during exercise and on physical work capacity.
    Koch G
    Arzneimittelforschung; 1970 Dec; 20(12):1857-9. PubMed ID: 5537080
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypotensive effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride].
    Palagi L; D'Elia M; Lanzara P; Criscione SM
    Clin Ter; 1970 Jun; 53(6):515-25. PubMed ID: 5527427
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemodynamic effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155) at rest and during exercise with special respect to the pulmonary circulation.
    Koch G
    Arzneimittelforschung; 1971 Jan; 21(1):57-61. PubMed ID: 5108382
    [No Abstract]   [Full Text] [Related]  

  • 5. [On hypertension therapy with 2-(2,6-dichlorophenylamino-)2-imidazoline hydrochloride (Catapresan)].
    Fritsch H; Bachmann GW; Lenhard J
    Med Klin; 1969 May; 64(18):842-7. PubMed ID: 4389564
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinico-experimental study of a hypotensive drug: 2(2,6-dichloro-phenylamino)-2-imidazoline hydrochloride].
    Caparello O; Contino A; Viola A; Pirro G
    Clin Ter; 1971 Jul; 57(6):553-62. PubMed ID: 5136489
    [No Abstract]   [Full Text] [Related]  

  • 7. [A major hypotensive drug with central action: catapressan].
    Spach MO; Imbs JL; Bloch R; Schwartz J
    Presse Med (1893); 1971 Jan; 79(3):101. PubMed ID: 5539690
    [No Abstract]   [Full Text] [Related]  

  • 8. [Behavior of hemodynamic values of patients with hypertension during dichlorphenylamino-imidazoline therapy].
    Pozenel H
    Wien Klin Wochenschr; 1969 Mar; 81(11):187-92. PubMed ID: 4935483
    [No Abstract]   [Full Text] [Related]  

  • 9. [Behavior of the electrocardiogram and radionephrogram during long-term treatment of arterial hypertension with 2-(2-6-dichlorophenylamino)-2-imidazoline hydrochloride].
    Curri G
    Clin Ter; 1970 Jun; 53(6):527-46. PubMed ID: 5527428
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of clonidin and chlorthalidone on blood pressure and glucose tolerance in hypertensive patients.
    Sung PK; Samet P; Yeh BK
    Curr Ther Res Clin Exp; 1971 May; 13(5):280-5. PubMed ID: 4998390
    [No Abstract]   [Full Text] [Related]  

  • 11. Trial of a new hypotensive drug--clonidine ("catapres").
    Trinker FR; Barnett AJ
    Med J Aust; 1970 Oct; 2(15):975-8. PubMed ID: 4920641
    [No Abstract]   [Full Text] [Related]  

  • 12. [New antihypertensive agent of the imidazoline series: 5-fluoro-methyl-imidazolidinylidene-benzamine-monohydrochloride (flutonidin)].
    Brunner H; Djawan S; Dorda W; Penner E; Grabner G
    Arzneimittelforschung; 1977; 27(8):1599-604. PubMed ID: 334188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Administration of a new hypotensive agent 2-(2,6-dichlorphenylamino) imidazoline chlorhydrate in the treatment of essential arterial hypertension].
    Borrello G
    Clin Ter; 1971 Apr; 57(1):9-29. PubMed ID: 5090286
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experimentation with a new imidazoline derivative (ST155) in the treatment of arterial hypertension].
    Ferreira EB; Eichemberg R; Berlitz MF
    Hospital (Rio J); 1969 Jun; 75(6):2139-51. PubMed ID: 5311472
    [No Abstract]   [Full Text] [Related]  

  • 15. [Preliminary clinical experiences on the antihypertensive effect of 2-(2-6 diclorophenylamino)-imidazoline].
    Corsini G; Di Filippo A; Cioffi A
    Rass Int Clin Ter; 1971 Feb; 51(4):237-46. PubMed ID: 5576946
    [No Abstract]   [Full Text] [Related]  

  • 16. [Our first experiences with the new hypotensive drug Catapresan].
    Grujić M; Robović Z; Perinović M; Rizvanbegović B; Sarić V; Vasiljević M
    Med Arh; 1968; 22(3):75-80. PubMed ID: 5191771
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hemodynamic changes following adminstration of dichlorophenylamino-imidazoline hydrochloride in acute and chronic experiments].
    Schneider KW; Gattenlöhner W; Müller W
    Verh Dtsch Ges Inn Med; 1967; 73():611-6. PubMed ID: 4873599
    [No Abstract]   [Full Text] [Related]  

  • 18. [On a new drug, chlorophenylamino-imidazoline, for treatment of hypertension in pregnancy].
    Cosmi EV; Bastianon V; Biancavilla F; Cilotti A
    Acta Anaesthesiol; 1970; 31():Suppl:129-34. PubMed ID: 5538003
    [No Abstract]   [Full Text] [Related]  

  • 19. [New chemotherapy in arterial hypertension].
    Chiti E
    Minerva Med; 1971 Nov; 62(84):4143-8. PubMed ID: 5136617
    [No Abstract]   [Full Text] [Related]  

  • 20. [First clinical experiences with a new hypotensive substance in severe forms of hypertension].
    Bergström J; Bergquist-Poppen M; Bucht H
    Arzneimittelforschung; 1966 Dec; 16(12):1606-10. PubMed ID: 6014792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.